Esomeprazole Magnesium Granule, Delayed Release
Product Images NDC 59651-805

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 59651-805). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Esomeprazole Fig1)

A line graph showing percent maintained over a 6-month period comparing Nexium 40 mg, Nexium 20 mg, Nexium 10 mg, and placebo groups. The y-axis represents percent maintained, and the x-axis represents months from 0 to 6. The graph illustrates different response rates for each group during the study duration.*

FDA Label Image

Package Label-principal Display Panel (40 mg (30 Packets Carton))

Packaging label for Esomeprazole Magnesium 40 mg delayed-release oral suspension granules by Aurobindo Pharma Limited. The label indicates it contains 30 single dose packets and is for prescription use only. Instructions note dispensing the Medication Guide separately and storage guidance is provided. The label includes the NDC number 59651-805-30 and distributor information for Aurobindo Pharma USA, Inc.*

FDA Label Image

Figure (Esomeprazole Fig2)

A line graph depicting the percentage maintained over a 6-month period for different treatments: NEXIUM 40 mg, NEXIUM 20 mg, NEXIUM 10 mg, and placebo. The x-axis represents months (0 to 6) and the y-axis shows percent maintained (0 to 100%). The graph compares the effectiveness of these doses versus placebo over time.*

FDA Label Image

Figure (Esomeprazole Fig3)

A line graph showing the percentage of patients symptom-free over 28 diary days for three groups: NEXIUM 40 mg, NEXIUM 20 mg, and placebo. The vertical axis represents the percent of patients symptom-free, and the horizontal axis represents diary days from 0 to 28. Both NEXIUM groups show higher symptom-free percentages compared to placebo throughout the period.*

FDA Label Image

Figure (Esomeprazole Fig4)

A line graph comparing the percent of patients symptom-free over 28 days of diary recording for Nexium 40 mg, Nexium 20 mg, and placebo. The y-axis shows percent of patients symptom-free, and the x-axis shows diary days from 0 to 28. Three data series are plotted with distinct markers and line styles, showing changes in symptom-free percentages over time for each group.*

FDA Label Image

Package Label-principal Display Panel (5 mg (Packet))

Packaging label for Esomeprazole Magnesium Delayed-Release Oral Suspension, 5 mg strength. The label indicates the product is an oral suspension in a delayed-release granule form. It carries Rx only status and the NDC code 59651-802-01. Labeler is Aurobindo Pharma Limited. Additional instructions for storage, preparation, and dosage are included on the label.*

FDA Label Image

Package Label-principal Display Panel (5 mg (30 Packets Carton))

Esomeprazole Magnesium 5 mg delayed-release oral suspension packaging label by Aurobindo Pharma Limited. The label states 'Rx only' and indicates the product is for delayed-release oral suspension in 30 single dose packets. It includes dosing instructions, storage conditions, and the NDC 59651-802-30. The label advises dispensing the Medication Guide separately to each patient and provides distributor information for Aurobindo Pharma USA, Inc.*

FDA Label Image

Package Label-principal Display Panel (20 mg (Packet))

Packaging label for Esomeprazole Magnesium 20 mg delayed-release oral suspension. The label includes dosage instructions, storage conditions, and directions for use. It shows the labeler as Aurobindo Pharma Limited and includes an NDC code 59651-804-03. The label indicates the product contains enteric-coated granules and instructs patients to receive a separate Medication Guide.*

FDA Label Image

Package Label-principal Display Panel (20 mg (30 Packets Carton))

Package label for Esomeprazole Magnesium 20 mg delayed-release oral suspension granules by Aurobindo Pharma Limited. The carton indicates 30 single-dose packets and includes dosage instructions and storage information. The label displays the NDC 59651-804-30 and emphasizes dispensing the Medication Guide with each patient.*

FDA Label Image

Package Label-principal Display Panel (40 mg (Packet))

Label for Esomeprazole Magnesium For Delayed-Release Oral Suspension 40 mg by Aurobindo Pharma Limited. The label states the product contains 40 mg of esomeprazole as enteric-coated granules in a packet form. It includes handling and dosing instructions, storage conditions, and a barcode. The label also notes the product is Rx only and provides a website for medication guides.*

FDA Label Image

Str (Esomeprazole Str)

Chemical structure of Esomeprazole Magnesium showing its molecular arrangement including aromatic rings, methoxy groups, and magnesium ion coordination with associated water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.